Genomma Lab InternacionalB de CV (MEX:LABB) Cyclically Adjusted FCF per Share: MXN1.92 (As of Mar. 2026)


MEX:LABB Genomma Lab Internacional SAB de CV MEX:LABB
66 GF Score
Price MXN14.97
GF Value MXN17.64
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Genomma Lab InternacionalB de CV Cyclically Adjusted FCF per Share?

Genomma Lab InternacionalB de CV MEX:LABB -0.47% 66 Cyclically Adjusted FCF per Share is MXN1.92 as of Mar. 2026. GuruFocus rates MEX:LABB with a GF Score™ of 66/100 and a GF Value™ of MXN17.64 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Genomma Lab InternacionalB de CV's adjusted free cash flow per share for the three months ended in Mar. 2026 was MXN-0.352. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN1.92 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Genomma Lab InternacionalB de CV's average Cyclically Adjusted FCF Growth Rate was 3.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 18.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 24.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Genomma Lab InternacionalB de CV was 30.40% per year. The lowest was 16.40% per year. And the median was 24.70% per year.

As of today (2026-06-27), Genomma Lab InternacionalB de CV's current stock price is MXN14.97. Genomma Lab InternacionalB de CV's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was MXN1.92. Genomma Lab InternacionalB de CV's Cyclically Adjusted Price-to-FCF of today is 7.80.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Genomma Lab InternacionalB de CV was 43.80. The lowest was 7.61. And the median was 17.53.


Genomma Lab InternacionalB de CV  (MEX:LABB) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Genomma Lab InternacionalB de CV's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=14.97/1.92
=7.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Genomma Lab InternacionalB de CV was 43.80. The lowest was 7.61. And the median was 17.53.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Genomma Lab InternacionalB de CV Cyclically Adjusted FCF per Share Related Terms


Genomma Lab InternacionalB de CV Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Genomma Lab InternacionalB de CV's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomma Lab InternacionalB de CV Cyclically Adjusted FCF per Share Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 1.24 1.64 1.94 2.06

Genomma Lab InternacionalB de CV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 1.88 1.86 2.06 1.92

MEX:LABB vs ZTS, UTHR, VTRS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Cyclically Adjusted Price-to-FCF falls into.


MEX:LABB
66GF Score
Genomma Lab Internacional SAB de CV MEX:LABB
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomma Lab InternacionalB de CV Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genomma Lab InternacionalB de CV's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.352/163.8112*163.8112
=-0.352

Current CPI (Mar. 2026) = 163.8112.

Genomma Lab InternacionalB de CV Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.394 101.905 0.633
201609 0.128 103.084 0.203
201612 0.468 105.002 0.730
201703 0.497 108.063 0.753
201706 0.221 108.339 0.334
201709 -0.573 109.628 -0.856
201712 0.885 112.114 1.293
201803 0.051 113.505 0.074
201806 0.073 113.373 0.105
201809 -0.143 115.130 -0.203
201812 1.424 117.530 1.985
201903 0.036 118.050 0.050
201906 -0.119 117.848 -0.165
201909 0.301 118.581 0.416
201912 0.743 120.854 1.007
202003 0.400 121.885 0.538
202006 -0.089 121.777 -0.120
202009 0.174 123.341 0.231
202012 1.192 124.661 1.566
202103 -0.028 127.574 -0.036
202106 -0.099 128.936 -0.126
202109 0.400 130.742 0.501
202112 0.986 133.830 1.207
202203 0.944 137.082 1.128
202206 0.202 139.233 0.238
202209 0.320 142.116 0.369
202212 0.598 144.291 0.679
202303 0.228 146.472 0.255
202306 0.417 146.272 0.467
202309 0.594 148.446 0.655
202312 0.853 151.017 0.925
202403 -0.182 152.947 -0.195
202406 0.418 153.551 0.446
202409 1.505 155.246 1.588
202412 0.729 157.378 0.759
202503 -0.264 158.761 -0.272
202506 0.434 160.180 0.444
202509 0.317 161.084 0.322
202512 1.588 163.188 1.594
202603 -0.352 163.811 -0.352

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN1.92 mean?
Genomma Lab InternacionalB de CV (MEX:LABB) has a Cyclically Adjusted FCF per Share of MXN1.92 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Genomma Lab InternacionalB de CV and its competitors.
Is Genomma Lab InternacionalB de CV's Cyclically Adjusted FCF per Share too high?
Genomma Lab InternacionalB de CV's current Cyclically Adjusted FCF per Share is MXN1.92. Overall, Genomma Lab InternacionalB de CV has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomma Lab InternacionalB de CV's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Genomma Lab InternacionalB de CV's Cyclically Adjusted FCF per Share of MXN1.92 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Genomma Lab InternacionalB de CV and its competitors. Genomma Lab InternacionalB de CV's current Cyclically Adjusted FCF per Share is MXN1.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomma Lab InternacionalB de CV stock overvalued right now?
Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV (MEX:LABB) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN17.64, compared to a current price of MXN14.97 — trading 15.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN1.92. Genomma Lab InternacionalB de CV's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Genomma Lab InternacionalB de CV (MEX:LABB), the current Cyclically Adjusted FCF per Share is MXN1.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genomma Lab InternacionalB de CV (MEX:LABB) Overvalued in 2026?

Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV stock appears to be undervalued. The current stock price of MXN14.97 is trading 15.1% below its estimated GF Value™ of MXN17.64. GuruFocus considers Genomma Lab InternacionalB de CV to be Modestly Undervalued.

Key valuation signals for MEX:LABB:

  • Cyclically Adjusted FCF per Share: MXN1.92
  • GF Value™: MXN17.64 vs. price of MXN14.97 (15.1% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the MEX:LABB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genomma Lab InternacionalB de CV Business Description

Other Exchanges GNMLF:USAGEKA:Germany
Address Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
66GF Score

Get the complete analysis for MEX:LABB

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN14.97
Price
MXN17.64
GF Value